The pharmaceutical industry continues to experience structural transformation as mental health becomes a central focus within global healthcare planning. Increasing recognition of psychiatric disorders as long-term medical conditions has significantly strengthened demand for therapeutic interventions. Antipsychotic medications now represent a vital